ArticleAnnals of hematology2026

Delayed-onset parkinsonism possibly associated with elranatamab treatment for relapsed/refractory multiple myeloma: a case report of a poorly characterized neurological event.

Asuka Kono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.